Background: Approximately 1/300 individuals in the general population are at risk for hereditary breast and ovarian cancer due to an inherited mutation in the BRCA1/BRCA2 genes. BRCA mutations are associated with dramatically increased risks for breast cancer, especially at younger ages, in addition to ovarian cancer. Enhanced screening and risk reduction strategies can significantly reduce associated morbidity and mortality. The United States Preventive Services Task Force (USPSTF) recommends identifying women at-risk for BRCA mutations for receipt of genetic counseling and if appropriate, testing. The Breast Cancer Genetics Referral Screening Tool (B-RST) is a validated screen endorsed by USPSTF to facilitate this process. This implementa...
Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not bee...
Importance Increasing BRCA1 and BRCA2 (collectively termed herein as BRCA) gene testing is required ...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
Background BRCA1 and BRCA2 mutations confer a substantial breast risk of developing ...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
BackgroundGuidelines recommend genetic counseling and testing for women with a pedigree suggestive o...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
BackgroundIn 2005, the United States Preventive Services Task Force (USPSTF) released guidelines whi...
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
The final publication is available at Springer via http://dx.doi.org/10.1007/s10897-017-0108-5Decrea...
This project seeks to support the clinical practice of using established guidelines for evaluating w...
Mutations in the BReast CAancer suspectibility genes BRCA 1 and 2 account for approximately 10% of b...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not bee...
Importance Increasing BRCA1 and BRCA2 (collectively termed herein as BRCA) gene testing is required ...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
Background BRCA1 and BRCA2 mutations confer a substantial breast risk of developing ...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
BackgroundGuidelines recommend genetic counseling and testing for women with a pedigree suggestive o...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
BackgroundIn 2005, the United States Preventive Services Task Force (USPSTF) released guidelines whi...
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
The final publication is available at Springer via http://dx.doi.org/10.1007/s10897-017-0108-5Decrea...
This project seeks to support the clinical practice of using established guidelines for evaluating w...
Mutations in the BReast CAancer suspectibility genes BRCA 1 and 2 account for approximately 10% of b...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not bee...
Importance Increasing BRCA1 and BRCA2 (collectively termed herein as BRCA) gene testing is required ...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...